Physician profile
Michael N Williams
NPI 1386623015
$1,197.14
in general payments reported to CMS, 2019-2025
14 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $464 · 2023: $212 · 2024: $151 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $743.83 | 2022-2025 | |
| Novo Nordisk INC | $84.50 | 2021-2025 | Wegovy |
| Lilly USA, LLC | $68.37 | 2021-2023 | Mounjaro |
| Biogen, INC. | $52.51 | 2022 | |
| Amgen INC. | $51.08 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.17 | 2022-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $39.94 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $21.98 | 2022 | |
| Daiichi Sankyo INC. | $17.67 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.41 | 2021 | |
| Pfizer INC. | $15.19 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.58 | 2021 | |
| Sk Life Science, INC. | $13.26 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.